Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.
Pipe SW, Collins P, Dhalluin C, Kenet G, Schmitt C, Buri M, Jiménez-Yuste V, Peyvandi F, Young G, Oldenburg J, Mancuso ME, Kavakli K, Kiialainen A, Deb S, Niggli M, Chang T, Lehle M, Fijnvandraat K.
Pipe SW, et al. Among authors: peyvandi f.
Blood. 2024 Apr 4;143(14):1355-1364. doi: 10.1182/blood.2023021832.
Blood. 2024.
PMID: 38127586
Free PMC article.
Clinical Trial.